iCAD (ICAD) Projected to Post Quarterly Earnings on Wednesday

iCAD (NASDAQ:ICAD - Get Free Report) will likely be posting its quarterly earnings results before the market opens on Wednesday, March 19th. Analysts expect iCAD to post earnings of ($0.05) per share and revenue of $4.72 million for the quarter. Parties interested in participating in the company's conference call can do so using this link.

iCAD Stock Performance

NASDAQ:ICAD traded down $0.13 during mid-day trading on Thursday, hitting $2.19. The company had a trading volume of 249,257 shares, compared to its average volume of 249,274. The business's fifty day moving average is $2.61 and its two-hundred day moving average is $2.03. The firm has a market cap of $58.12 million, a P/E ratio of -16.85 and a beta of 1.95. iCAD has a fifty-two week low of $1.18 and a fifty-two week high of $3.78.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised iCAD from a "sell" rating to a "hold" rating in a research report on Thursday, February 20th.

About iCAD

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.